Answers are grounded in this paper and cite their sources.
Escherichia coli that has been genetically manipulated by recombinant DNA technology to synthesize human insulin polypeptides (A chain, B chain, or proinsulin) contains prominent cytoplasmic inclusion bodies. The amount of inclusion product within the cells corresponds to the quantity of chimeric protein formed by the bacteria. At peak production, the inclusion bodies may occupy as much as 20 percent of the Escherichia coli cellular volume.
No takes yet. Share an insight, caveat, or question.
Williams et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: